Barclays Boosts Hinge Health (NYSE:HNGE) Price Target to $62.00

Key Points

• Barclays has raised Hinge Health's price target from $51.00 to $62.00, maintaining an "overweight" rating and indicating a potential upside of 13.08% from the current price.
• Multiple research firms, including Evercore ISI and Stifel Nicolaus, have also increased their price targets for Hinge Health, with a general consensus rating of "Buy."
• Hinge Health's stock has shown strong performance, trading up 13.7% recently, with a current price of $54.83.

Hinge Health (NYSE:HNGE - Get Free Report) had its target price upped by research analysts at Barclays from $51.00 to $62.00 in a report issued on Wednesday,Benzinga reports. The brokerage presently has an "overweight" rating on the stock. Barclays's price target suggests a potential upside of 13.08% from the company's current price.

HNGE has been the topic of several other research reports. Evercore ISI lifted their price target on shares of Hinge Health from $50.00 to $60.00 and gave the stock an "outperform" rating in a research note on Wednesday. Stifel Nicolaus lifted their target price on shares of Hinge Health from $48.00 to $55.00 and gave the company a "buy" rating in a research note on Friday, August 1st. JMP Securities began coverage on shares of Hinge Health in a research note on Monday, July 14th. They set a "market outperform" rating and a $58.00 target price on the stock. Needham & Company LLC lifted their target price on shares of Hinge Health from $47.00 to $59.00 and gave the company a "buy" rating in a research note on Wednesday. Finally, Citigroup began coverage on shares of Hinge Health in a research note on Monday, July 14th. They set an "outperform" rating on the stock. One equities research analyst has rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Hinge Health has a consensus rating of "Buy" and a consensus target price of $54.57.

Hinge Health Trading Up 13.7%

HNGE stock traded up $6.61 on Wednesday, hitting $54.83. The company had a trading volume of 831,355 shares, compared to its average volume of 888,003. Hinge Health has a 12-month low of $33.42 and a 12-month high of $57.10. The company has a 50-day moving average of $43.52.

Institutional Trading of Hinge Health

A number of large investors have recently made changes to their positions in the business. CHURCHILL MANAGEMENT Corp bought a new stake in shares of Hinge Health in the 2nd quarter worth about $828,000. Strategic Blueprint LLC bought a new stake in shares of Hinge Health in the 2nd quarter worth about $346,000. FNY Investment Advisers LLC bought a new stake in shares of Hinge Health in the 2nd quarter worth about $310,000. Finally, Emerald Advisers LLC bought a new stake in shares of Hinge Health in the 2nd quarter worth about $108,000.

Hinge Health Company Profile

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.